CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 131 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $707,000 | +7.8% | 91,500 | -8.6% | 0.00% | 0.0% |
| Q4 2020 | $656,000 | -3.2% | 100,112 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $678,000 | -18.6% | 102,012 | +2.0% | 0.00% | 0.0% |
| Q2 2020 | $833,000 | +18.3% | 100,012 | +8.9% | 0.00% | 0.0% |
| Q1 2020 | $704,000 | -5.4% | 91,800 | +2.6% | 0.00% | 0.0% |
| Q4 2019 | $744,000 | +41.2% | 89,500 | +25.4% | 0.00% | 0.0% |
| Q3 2019 | $527,000 | -34.0% | 71,400 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $799,000 | -23.5% | 71,185 | -26.8% | 0.00% | 0.0% |
| Q1 2019 | $1,045,000 | +3.8% | 97,200 | +45.7% | 0.00% | 0.0% |
| Q4 2018 | $1,007,000 | -7.0% | 66,716 | +14.0% | 0.00% | 0.0% |
| Q3 2018 | $1,083,000 | – | 58,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |